# China NMPA Drug Inspection - Fujian Pacific Pharmaceutical Co., Ltd. - Ibuprofen sustained-release capsules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/fujian-pacific-pharmaceutical-co-ltd/3ab3e7de-2516-4712-b522-43fc8e249f3c/
Source feed: China

> China NMPA drug inspection for Fujian Pacific Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Ibuprofen sustained-release capsules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Fujian Pacific Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Ibuprofen sustained-release capsules
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/fujian-pacific-pharmaceutical-co-ltd/4594920d-f178-4a6d-b732-97c71b5b968d/